Hjem › Post-COVID-tilstander (lang-COVID) › Missouri
Kliniske studier for Post-COVID-tilstander (lang-COVID) i Missouri
4 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i Missouri.
Byer i Missouri
Offisiell studietekst (engelsk)
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- Saint Louis University Center for Vaccine Development, St Louis
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 64 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Kansas City
- Research Site, St Louis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05624450Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
- Washington University in Saint Louis Department of Emergency Medicine, Emergency Care Research Core, St Louis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 60 · Alle kjønn · Oppdatert 12. mar. 2026 · NCT06848309EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- St. Louis Children's Hospital, St Louis
- Washington University School of Medicine, St Louis
RekruttererFase 3
Alder 0 til 17 · Alle kjønn · Oppdatert 17. jul. 2025 · NCT05261139Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.